EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal Transition

Qiong- Dan Hu, Hong-Lian Wang, Jian Liu, Tao He, Rui-Zhi Tan, Qiong Zhang, Hong-Wei Su, Fahsai Kantawong, Hui-Yao Lan, Li Wang iD

Advanced Science · 2023-11 · 10 (32)

DOI: 10.1002/advs.202304360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.09.2023. Verfasst von Qiong- Dan Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Integrated Traditional Chinese and Western Medicine, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical Uni…. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental, Podocytes. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Luzhou-Southwest Medical University Science and Technology Strategic Cooperation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Podocyte injury plays a critical role in the progression of focal segmental glomerulosclerosis (FSGS). Here, it is reported that B‐cell translocation gene 2 (Btg2) promotes Adriamycin (ADR)‐induced FSGS via Smad3‐dependent podocyte‐mesenchymal transition. It is found that in FSGS patients and animal models, Btg2 is markedly upregulated by podocytes and correlated with progressive renal injury. Podocyte‐specific deletion of Btg2 protected against the onset of proteinuria and glomerulosclerosis in ADR‐treated mice along with inhibition of EMT markers such as α‐SMA and vimentin while restoring epithelial marker E‐cadherin. In cultured MPC5 podocytes, overexpression of Btg2 largely promoted ADR and TGF‐β1‐induced EMT and fibrosis, which is further enhanced by overexpressing Btg2 but blocked by disrupting Btg2. Mechanistically, Btg2 is rapidly induced by TGF‐β1 and then bound Smad3 but not Smad2 to promote Smad3 signaling and podocyte EMT, which is again exacerbated by overexpressing Btg2 but blocked by deleting Btg2 in MPC5 podocytes. Interestingly, blockade of Smad3 signaling with a Smad3 inhibitor SIS3 is also capable of inhibiting Btg2 expression and Btg2‐mediated podocyte EMT, revealing a TGF‐β/Smad3‐Btg2 circuit mechanism in Btg2‐mediated podocyte injury in FSGS. In conclusion, Btg2 is pathogenic in FSGS and promotes podocyte injury via a Smad3‐dependent EMT pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulosclerosis, Focal SegmentalPodocytesAnimalsHumansMiceDoxorubicinKidneyTransforming Growth Factor betaTransforming Growth Factor beta1Immediate-Early ProteinsTumor Suppressor ProteinsSmad3 Protein

Stichwörter der Autor:innen

Btg2TGF-β/Smad3 signalingepithelial-mesenchymal transitionfocal segmental glomerulosclerosispodocyte

Substanzen

DoxorubicinTransforming Growth Factor betaTransforming Growth Factor beta1Btg2 protein, mouseImmediate-Early ProteinsTumor Suppressor ProteinsSmad3 protein, mouseSmad3 Protein

Autor:innen und Institutionen

  • Research Center of Integrated Traditional Chinese and Western Medicine, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Sichuan, 646000, China.
  • Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, 50200, Thailand.
  • Department of Nephrology, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Sichuan, 646000, China.
  • Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, 646000, China.
  • Department of Nephrology, the Affiliated Hospital of Southwest Medical University, Sichuan, 646000, China.
  • Cancer Medicine Institute, College of Basic Medical Sciences, Southwest Medical University, Sichuan, 646000, China.

ORCID-Profile: Li Wang

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Luzhou-Southwest Medical University Science and Technology Strategic Cooperation Project
  • Innovation Team Project of the Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University
  • Research Grants Council of Hong Kong

Zitieren

APA

Dan Hu, Q., Wang, H. L., Liu, J., He, T., Tan, R. Z., Zhang, Q., Su, H. W., Kantawong, F., Lan, H. Y., & Wang, L. (2023). Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal Transition. Advanced Science, 10(32). https://doi.org/10.1002/advs.202304360

Vancouver

Dan Hu Q, Wang HL, Liu J, He T, Tan RZ, Zhang Q, et al. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal Transition. Advanced Science. 2023;10(32). doi:10.1002/advs.202304360

BibTeX
@article{DanHu2023,
  author = {Dan Hu, Qiong- and Wang, Hong-Lian and Liu, Jian and He, Tao and Tan, Rui-Zhi and Zhang, Qiong and Su, Hong-Wei and Kantawong, Fahsai and Lan, Hui-Yao and Wang, Li},
  title = {Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal Transition},
  journal = {Advanced Science},
  year = {2023},
  volume = {10},
  number = {32},
  doi = {10.1002/advs.202304360}
}
Kostenlos starten →